Sanctuary Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Sanctuary Advisors’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.34M	Buy	14,811 +325	+2%	+$43.9K	0.01%	973
2026 Q1	$1.85M	Sell	14,486 -454	-3%	-$56.7K	0.01%	991
2025 Q4	$1.82M	Buy	14,940 +3,227	+28%	+$370K	0.01%	983
2025 Q3	$1.17M	Sell	11,713 -1,377	-11%	-$124K	0.01%	1196
2025 Q2	$1.09M	Sell	13,090 -1,237	-9%	-$98.7K	0.01%	1169
2025 Q1	$1.16M	Sell	14,327 -845	-6%	-$75.5K	0.01%	1062
2024 Q4	$1.42M	Buy	15,172 +6	+0%	+$581	0.01%	1053
2024 Q3	$1.46M	Buy	15,166 +1,711	+13%	+$168K	0.01%	1059
2024 Q2	$1.12M	Buy	+13,455	New	+$1.21M	0.01%	1131

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Sanctuary Advisors's XBI Position: Q2 2026 in Review

Sanctuary Advisors increased its State Street SPDR S&P Biotech ETF (XBI) stake by 2.2% in Q2 2026, buying an estimated $43.9K and bringing the position to 14,811 shares worth $2.34M. The position accounts for 0.01% of the portfolio, ranked #973.

Sanctuary Advisors first reported a position in XBI in Q2 2024 and has held it in 9 quarters since. 936 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Sanctuary Advisors held 14,811 shares of State Street SPDR S&P Biotech ETF worth $2.34M as of Q2 2026.
Sanctuary Advisors bought 325 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $43.9K.
State Street SPDR S&P Biotech ETF made up 0.01% of Sanctuary Advisors's portfolio in Q2 2026, its #973 holding.
Sanctuary Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q2 2024 and has held it in 9 quarters since.
936 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Sanctuary Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.